In humans, inactivating mutations of hepcidin result in a rare form of juvenile haemochromatosis [9], whereas hepcidin overexpression in inflammation causes anaemia of chronic diseases with features of iron restricted erythropoiesis [10]. The gene discussed is HAMP; the disease is anemia.